Background {#Sec1}
==========

Diabetes is an important cause of mortality, morbidity, and health-system costs worldwide \[[@CR1]--[@CR3]\]. The number of diabetes deaths in the world nearly doubled between 1990 and 2010 \[[@CR4]\]. In 2015, the International Diabetes Federation estimated that 75% of people with diabetes live in low- and middle-income countries, particularly China, which has the largest number of people with diabetes in the world (109.6 million) \[[@CR5]\]. Additionally, rural areas of China have lower economic development than urban areas and the people have poorer knowledge of type 2 diabetes mellitus (T2DM) control and prevention \[[@CR6]\]. In this context, T2DM has been an important public health problem in rural China.

Adiposity is the most important modifiable risk factor for T2DM \[[@CR7], [@CR8]\]. Although body mass index (BMI) has been widely used as a reliable and simple measure of obesity, many people with normal BMI, called "metabolically obese but normal weight (MONW)", are characterized by a cluster of metabolic risk factors, with significantly increased incidence of T2DM in many ethnic groups \[[@CR9]--[@CR11]\]. Moreover, normal-weight people may not monitor their health indicators or take prevention measures for T2DM. Therefore, early identification of T2DM for normal-weight people is necessary. Particularly Chinese people, despite their lower absolute BMI, are more prone to visceral fat accumulation and insulin resistance (IR) than are Western populations \[[@CR12], [@CR13]\]. However, data are limited on the prevention of T2DM for normal-weight people in China.

Triglyceride glucose (TyG) index has been used as an inexpensive and reliable surrogate indicator to identify IR and T2DM \[[@CR14]--[@CR16]\]. The hyperinsulinemic-euglycemic clamp is considered the gold standard to define IR \[[@CR16]\], but the technique is difficult to use in large epidemiology investigations because it is time-consuming, costly, and complex.

To our knowledge, the relationship between TyG and incident T2DM for normal-weight Chinese people has not been studied. Therefore, we designed a prospective cohort study to explore the relationship in normal-weight rural Chinese people.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

This study was a population-based, prospective cohort study, and participants were selected by cluster randomization from eligible candidates listed in the residential registration record from the rural district in Luoyang City, Henan Province, in the middle of China, for a baseline examination during July to August of 2007 and July to August of 2008. First, Xin'an County was selected from Luoyang area, and then 2 towns were randomly selected from Xin'an County. Finally, a total of 64 villages were investigated from selected towns. Participants were excluded if they were (1) unable to answer the questionnaire; (2) unable to complete blood sampling or anthropometric or blood pressure measurements; and (3) known to have severe psychological disorders, Alzheimer's disease, dementia, AIDS or other infectious disease. Ultimately, we recruited 20,194 participants ≥18 years old. During July to August of 2013 and July to October of 2014, all participants were invited to undergo a follow-up examination, and 17,265 participants (response rate 85.5%) were re-investigated. The other characteristics for the study population have been previously published \[[@CR17], [@CR18]\]. For the present study, we examined data for 8003 participants with normal weight (BMI 18.5--23.9 kg/m^2^ according to the recommendations of Working Group on Obesity of China) \[[@CR19]\]. After excluding 430 participants with T2DM at baseline (one with gestational diabetes also), 121 participants who died due to cancer, 64 participants who died due to cardiovascular disease, 132 participants who died due to stroke, 163 participants who died due to accidents or other causes, and 1387 participants with missing lipid profile measures during follow-up, we had 5706 (3195 women) eligible for the current analyses.

Baseline examination and data collection {#Sec4}
----------------------------------------

Baseline data were collected at local community clinics in the participants' residential areas. Trained research staff administered a standard questionnaire to collect information on demographic characteristics, medical history, and lifestyle risk factors. Participants who had not smoked \>100 cigarettes in their lifetime were considered never-smokers; the others were considered smokers \[[@CR20]\]. Alcohol consumption was defined as drinking alcohol \>12 times during the last year. Physical activity level was classified by the International Physical Activity Questionnaire scoring protocol \[[@CR21]\]. Family history of diabetes was defined as having at least one first-degree family member with diabetes.

Participants were asked to wear light clothes and be barefoot when measuring anthropometric indices. Body weight and height were measured to the nearest 0.1 kg and 0.1 cm, respectively, by trained investigators under standardized conditions following a standard protocol. BMI was calculated as weight in kilograms divided by the square of height in meters. With participants standing, waist circumference (WC) was measured midway between the lower edge of the costal arch and the upper edge of the iliac crest to the nearest 0.1 cm. Participants were measured twice, and the average was used. Waist-to-height ratio (WHtR) was determined by WC (cm) divided by height (cm). Central obesity was defined by WC ≥90 cm for men and ≥80 cm for women or WHtR ≥0.5 according to previous reports \[[@CR22], [@CR23]\]. Blood pressure was measured by using an electronic sphygmomanometer (Omron, HEM-770AFuzzy, Kyoto, Japan) after at least a 5-min rest, with participants in a seated position, according to the American Heart Association standardized protocol \[[@CR24]\]. The measurements were repeated three times with a 30-s interval, and the average was used for analysis.

Blood samples were obtained after an overnight fast of at least 8 h. Levels of fasting plasma glucose (FPG), triglycerides (TG), total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-C) were measured by using a HTACHI automatic clinical analyzer (Model 7060, Tokyo). Low-density lipoprotein cholesterol (LDL-C) level was calculated by the Friedewald formula \[[@CR25]\]. TyG was calculated as ln\[TG (mg/dl) × FPG (mg/dl)/2\] \[[@CR14]\]. The difference in TyG (TyG-D) was calculated as TyG value at the end of follow-up minus that at baseline.

T2DM was defined as FPG ≥7.0 mmol/l and/or current treatment with anti-diabetes medication according to the China guideline for type 2 diabetes \[[@CR26]\].

Follow-up examination {#Sec5}
---------------------

Study participants or their proxies at their current address underwent in-depth interviews to ascertain disease status and vital information; hospital records and death certificates were obtained as well. Data collection at follow-up was the same as at baseline.

Statistical analysis {#Sec6}
--------------------

All continuous variables are described with median (interquartile range) because of skewed distribution. Categorical variables are presented as number (percentage). Study participants were classified by four TyG quartiles. The linear trend for baseline characteristics was tested by linear regression for continuous variables and logistic regression for categorical variables.

A Cox proportional-hazard regression model was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident T2DM by quartiles of TyG and TyG-D, with the lowest quartile as the reference. Besides the unadjusted model, 3 other models were fitted: model 1, controlling for gender, age, family history of diabetes, and WC; model 2, additionally adjusted for education level, marital status, smoking, alcohol consumption, and physical activity; model 3, adjusted for variables included in model 2 plus systolic blood pressure (SBP), diastolic blood pressure (DBP) and TC, HDL-C, and LDL-C levels (all of these factors related to FPG level). The linear trends across TyG and TyG-D quartiles were evaluated by a median value within each quartile as a continuous variable. The receiver operating characteristic (ROC) curve and area under the ROC curve (AUC) were used to compare the ability of baseline TyG index, WC and WHtR to predict risk of T2DM at follow-up.

The cumulative incidence of T2DM and cumulative incidence curves by TyG quartile were examined by competing risk regression analysis. Generalized additive models were used to test for nonlinearity in the analysis of risk of T2DM by TyG index with adjustment for potential confounding variables (gender, age, and family history of diabetes, WC, SBP, DBP, and TC, HDL-C and LDL-C levels).

Sensitivity analysis was conducted to assess the robustness of the results by rerunning all the models excluding 899 participants with metabolic syndrome (Third Report of the National Cholesterol Education Program's Adult Treatment Panel criteria components modified for WC cutoff according to World Health Organization Asia Pacific guidelines) \[[@CR27]\] and 202 participants with impaired FPG level (FPG 6.1--7.0 mmol/l) \[[@CR26], [@CR28]\] at baseline. ROC analysis, competing risk regression analysis and generalized additive model construction involved use of STATA v12.0 (STATA Corp, College Station, TX, USA) and other analyses involved SAS 9.1 (SAS Inst., Cary, NC, USA). Two-sided *P* \< 0.05 was considered statistically significant.

Results {#Sec7}
=======

Baseline characteristics of study participants {#Sec8}
----------------------------------------------

Data were analyzed for 5706 normal-weight people (median age 51 years \[interquartile range 40--60\]). After 34,246.00 person-years of follow-up, T2DM developed in 194 participants; the overall incidence of T2DM was 5.66/1000 person-years. Age, BMI, WC, WHtR, SBP, and DBP were increased by quartiles of TyG index (all *P* ~trend~ \< 0.001) (Table [1](#Tab1){ref-type="table"}). Compared with participants with quartile 1 of TyG index, those with higher quartiles were more frequently older, women, with less education and less physically active. Marital status, smoking, alcohol consumption, and family history of diabetes were similar across TyG quartiles. FPG, TC, TG, and LDL-C levels were increased and HDL-C level was decreased with increasing TyG quartile (all *P* ~trend~ \< 0.001).Table 1Baseline characteristics of study participants stratified by quartiles of triglyceride glucose (TyG) indexVariablesTyG index quartiles*P* ~trend~Quartile 1 (\<8.16) n = 1423Quartile 2 (8.16--8.47) n = 1422Quartile 3 (8.48--8.81) n = 1429Quartile 4 (≥8.82) n = 1424Age (years)44.00 (36.00--56.00)51.00 (40.00--60.00)52.00 (43.00--61.00)54.00 (44.00--62.00)*\<0.001*Men618 (43.43)679 (47.75)638 (44.65)571 (40.10)*0.03*High school or above156 (10.96)180 (12.66)140 (9.80)121 (8.50)*\<0.01*Married/cohabiting1274 (89.53)1294 (91.06)1306 (91.39)1303 (91.50)0.07Smoking436 (30.64)495 (34.81)456 (31.91)411 (28.86)0.14Drinking160 (11.24)166 (11.67)179 (12.53)161 (11.31)0.78Physical activity Low793 (55.73)777 (54.64)755 (52.83)692 (48.60)*\<0.001* Middle282 (19.82)279 (19.62)290 (20.29)321 (22.54) High348 (24.46)366 (25.74)384 (26.87)411 (28.86)Family history of diabetes^a^60 (5.24)62 (5.36)56 (4.83)70 (6.03)0.54BMI (kg/m^2^)21.53 (20.39--22.60)21.57 (20.32--22.73)21.94 (20.69--23.01)22.35 (21.20--23.24)*\<0.001*WC (cm)73.75 (70.25--78.00)74.50 (70.75--78.75)76.03 (71.93--80.50)78.25 (74.10--82.15)*\<0.001*WHtR0.46 (0.44--0.49)0.47 (0.44--0.49)0.48 (0.45--0.51)0.49 (0.47--0.52)*\<0.001*FPG (mmol/l)5.00 (4.71--5.31)5.18 (4.86--5.48)5.27 (4.98--5.62)5.43 (5.14--5.81)*\<0.001*SBP (mmHg)113.67 (105.33--126.00)118.00 (108.00--130.67)119.00 (109.33--131.67)123.00 (112.33--136.67)*\<0.001*DBP (mmHg)71.67 (66.33--78.33)74.00 (68.00--81.00)74.67 (69.00--81.67)77.00 (70.00--84.00)*\<0.001*TC (mmol/l)3.79 (3.38--4.27)4.10 (3.65--4.64)4.37 (3.85--4.96)4.72 (4.09--5.28)*\<0.001*TG (mmol/l)0.69 (0.59--0.78)1.01 (0.92--1.10)1.35 (1.23--1.48)2.03 (1.78--2.56)*\<0.001*HDL-C (mmol/l)1.25 (1.10--1.44)1.21 (1.04--1.39)1.17 (1.02--1.36)1.10 (0.95--1.25)*\<0.001*LDL-C (mmol/l)2.20 (1.90--2.60)2.40 (2.00--2.90)2.60 (2.10--3.10)2.60 (2.10--3.10)*\<0.001*TyG index7.93 (7.77--8.06)8.33 (8.25--8.41)8.64 (8.57--8.73)9.08 (8.94--9.31)*\<0.001*Significant *P* values (*P* \< 0.05) are in italicsData are median (interquartile range) or no. (%)*BMI* body mass index, *WC* waist circumference, *WHtR* waist-to-height ratio, *FPG* fasting plasma glucose, *SBP* systolic blood pressure, *DBP* diastolic blood pressure, *TC* total cholesterol, *TG* triglyceride, *HDL-C* high-density lipoprotein cholesterol, *LDL-C* low-density lipoprotein cholesterol, *TyG* triglyceride glucose^a^Partial data deletion

Risk of incident T2DM by quartiles of TyG and TyG-D {#Sec9}
---------------------------------------------------

With increasing TyG quartile, T2DM incidence increased substantially for normal-weight people, reaching an incidence of 10.48/1000 person-years for quartile 4 of TyG index (Table [2](#Tab2){ref-type="table"}). On competing risk analysis, the cumulative risk of T2DM increased over time by baseline TyG quartile (Fig. [1](#Fig1){ref-type="fig"}) and remained significant even after adjustment for potential confounding factors (adjusted HR \[aHR\] \[model 3\] 2.48 \[95% CI 1.20--5.11\], 3.77 \[1.83--7.79\], and 5.30 \[2.21--12.71\] for quartiles 2, 3 and 4 versus quartile 1 of TyG index) (Table [2](#Tab2){ref-type="table"}). Moreover, risk of incident T2DM was increased with increasing TyG quartile (*P* ~trend~ \< 0.001). Risk of incident T2DM was increased with quartile 4 versus quartile 1 of TyG-D index (aHR 3.91 \[2.22--6.87\]; model 3; Table [2](#Tab2){ref-type="table"}) (*P* ~trend~ \< 0.001).Table 2Risk of incident type 2 diabetes mellitus (T2DM) by quartiles of TyG and TyG-DQuartile 1Quartile 2Quartile 3Quartile 4*P* ~trend~TyG Range\<8.168.16 to 8.478.48 to 8.81≥8.82 No. of cases18355288 No. of person-years8740.508526.838529.258399.50 Incidence rate^a^2.064.106.1010.48\<0.001 Unadjusted model1 (ref)2.36 (1.33--4.16)3.58 (2.09--6.12)6.30 (3.78--10.50)\<0.001 Multivariable adjusted model 1^b^1 (ref)2.38 (1.17--4.85)3.71 (1.89--7.29)5.54 (2.87--10.71)\<0.001 Multivariable adjusted model 2^c^1 (ref)2.49 (1.22--5.08)3.89 (1.98--7.65)5.69 (2.94--11.01)\<0.001 Multivariable adjusted model 3^d^1 (ref)2.48 (1.20--5.11)3.77 (1.83--7.79)5.30 (2.21--12.71)\<0.001TyG-D Range\<−0.27−0.27 to 00.01 to 0.31≥0.32 No. of cases41393083 No. of person-years8520.009747.087373.008556.00 Incidence rate^a^4.814.004.079.70\<0.001 Unadjusted model1 (ref)0.95 (0.58--1.55)1.15 (0.68--1.93)2.19 (1.41--3.39)\<0.001 Multivariable adjusted model 1^b^1 (ref)0.92 (0.52--1.63)1.09 (0.59--2.03)2.51 (1.50--4.19)\<0.001 Multivariable adjusted model 2^c^1 (ref)0.92 (0.52--1.64)1.10 (0.59--2.05)2.52 (1.51--4.22)\<0.001 Multivariable adjusted model 3^d^1 (ref)1.14 (0.63--2.09)1.54 (0.80--2.99)3.91 (2.22--6.87)\<0.001Data are hazard ratios (HRs) and 95% confidence intervals (95% CIs)*TyG* triglyceride glucose index, *TyG-D* difference in TyG value at the end of follow-up minus that at baseline^a^Per 1000 person-years^b^Adjusted for gender, age, family history of diabetes and WC^c^Adjusted for variables in ^b^ as well as education level, marital status, smoking, alcohol consumption and physical activity^d^Adjusted for variables in ^c^ as well as SBP, DBP and TC, HDL-C and LDL-C levels Fig. 1Cumulative incidence of type 2 diabetes mellitus (T2DM) by quartiles of triglyceride glucose (TyG) index. *Gray dash line* quartile 1; *gray solid line* quartile 2; *black dash line* quartile 3; *black solid line* quartile 4

Risk of incident T2DM was increased with per-unit increase in TyG index for both genders and all age groups (Fig. [2](#Fig2){ref-type="fig"}). With per-unit increase of baseline TyG value, the risk of T2DM increased twofold for men and fourfold for women (aHR 2.05 \[95% CI 1.23--3.41\] and 4.04 \[2.76--5.92\], respectively; model 2). Risk of incident T2DM was increased with per-unit increase in TyG index for older men (aHR, 3.75 \[1.75--8.05\]) and women of all age groups. The risk with high TyG-D value was significantly associated with middle and older age groups for both men and women. These results were consistent with abdominal fat distribution for different sex/age groups (Table [3](#Tab3){ref-type="table"}). With WC criteria, the prevalence of central obesity was low for men of all age groups (1.62--1.91%), but with WHtR criteria, it was highest for older men (23.82%) as compared with young and middle-aged men. Regardless of the criteria used, women had the high prevalence of central obesity for all age groups.Fig. 2Association of T2DM and TyG index or TyG-D by sex and/or age groups. Data are hazard ratios (HRs) and 95% confidence limits (95% CLs). *T2DM* type 2 diabetes mellitus, *TyG index* triglyceride glucose index, *TyG-D* difference in TyG value at the end of follow-up minus that at baseline. *Asterisk* adjusted for gender, age, education level, marital status, smoking, alcohol consumption, physical activity, family history of diabetes and waist circumference (WC) Table 3The prevalence of central obesity at baseline based on WC and WHtR criteria by age and genderNDefined by WCDefined by WHtRNo. of individualsPrevalence (%)No. of individualsPrevalence (%)Men 18--3945081.78408.89 40--591259241.9120316.14 ≥60802131.6219123.82Women 18--3984610011.8212915.25 40--59162230718.4955834.42 ≥6072724133.2042458.40*WC* waist circumference, *WHtR* waist-to-height ratio

ROC analyses for TyG, WC, and WHtR to predict the incident risk of T2DM {#Sec10}
-----------------------------------------------------------------------

For men, the AUC for TyG, WC, and WHtR was 0.602 (0.583--0.622), 0.596 (0.576--0.615), and 0.608 (0.588--0.627), respectively (Fig. [3](#Fig3){ref-type="fig"}). The AUC for TyG index, WC, and WHtR was larger for women than men: 0.733 (0.717--0.748), 0.630 (0.613--0.647), and 0.659 (0.643--0.676), respectively, with significant differences between AUCs for TyG index and WC (*P* = 0.005) and TyG index and WHtR (*P* = 0.04). The best TyG value for diagnosis of T2DM was 8.64 (sensitivity 0.522, specificity 0.642) for men and 8.76 (sensitivity 0.650, specificity 0.702) for women.Fig. 3ROC curves for TyG, WC, and WHtR for predicting T2DM among men (**a**), and women (**b**). *ROC* receiver operating characteristic, *TyG index* triglyceride glucose index, *WC* waist circumference, *WHtR* waist-to-height ratio, *T2DM* type 2 diabetes mellitus. *Solid black line* TyG; *solid gray line*,WC; *dotted black line* WHtR. *Asterisk* compared with TyG

Generalized additive plot for TyG and T2DM risk {#Sec11}
-----------------------------------------------

Figure [4](#Fig4){ref-type="fig"} shows the nonparametric smoothed exposure--response relationship between TyG index and T2DM risk (TyG index as a continuous variable). The function for TyG index showed significant nonlinearity (*P* \< 0.001) with T2DM risk, and the slope increased with increasing TyG index.Fig. 4Generalized additive model plot for risk of T2DM and TyG index. Adjusted for gender, age, family history of diabetes, waist circumference (WC), systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C). *T2DM* type 2 diabetes mellitus, *TyG index* triglyceride glucose index

Results of sensitivity analysis {#Sec12}
-------------------------------

The main results of the current study were consistent when analyses were restricted to participants without metabolic syndrome and impaired FPG level at baseline (Table [4](#Tab4){ref-type="table"}). After 27,801.75 person-years of follow-up, the T2DM incidence was 3.45/1000 person-years (96 cases) (data not shown). Risk of T2DM was increased by 4.29-fold (95% CI 1.72--10.67) and 5.88-fold (95% CI 2.06--16.76) with quartiles 3 and 4 versus quartile 1 of TyG, respectively (model 3). A generalized additive model plot showed that TyG index had significant nonlinearity with T2DM risk (*P* = 0.25) (Fig. [5](#Fig5){ref-type="fig"}), but the association was almost linear after excluding participants with metabolic syndrome and impaired FPG level at baseline.Table 4Risk of incident T2DM for participants without metabolic syndrome and impaired FPG level at baselineQuartile 1Quartile 2Quartile 3Quartile 4*P* ~trend~TyG Range\<8.098.09 to 8.398.40 to 8.68≥8.69 No. of cases12153237 No. of person-years7078.676945.586914.006832.42 Incidence rate^a^1.702.164.635.42\<0.001 Unadjusted model1 (ref)1.42 (0.67--3.04)3.10 (1.60--6.03)3.75 (1.95--7.23)\<0.001 Multivariable adjusted model 1^b^1 (ref)1.19 (0.43--3.30)3.50 (1.50--8.16)4.36 (1.89--10.05)\<0.001 Multivariable adjusted model 2^c^1 (ref)1.25 (0.45--3.46)3.68 (1.57--8.60)4.54 (1.97--10.47)\<0.001 Multivariable adjusted model 3^d^1 (ref)1.34 (0.48--3.76)4.29 (1.72--10.67)5.88 (2.06--16.76)\<0.001TyG-D Range\<−0.23−0.23 to 00.01 to 0.35≥0.35 No. of cases17142045 No. of person-years6912.757101.506797.336959.08 Incidence rate^a^2.461.972.946.47\<0.001 Unadjusted model1 (ref)0.78 (0.37--1.64)1.37 (0.69--2.70)2.40 (1.31--4.39)\<0.001 Multivariable adjusted model 1^b^1 (ref)0.78 (0.33--1.84)0.97 (0.41--2.28)2.86 (1.40--5.84)\<0.001 Multivariable adjusted model 2^c^1 (ref)0.80 (0.34--1.90)0.98 (0.42--2.32)2.90 (1.42--5.93)\<0.001 Multivariable adjusted model 3^d^1 (ref)0.99 (0.42--2.36)1.43 (0.60--3.43)4.56 (2.14--9.70)\<0.001Data are hazard ratios (HRs) and 95% confidence intervals (95% CIs)^a^Per 1000 person-years^b^Adjusted for gender, age, family history of diabetes and WC^c^Adjusted for variables in ^b^ as well as education level, marital status, smoking, alcohol consumption and physical activity^d^Adjusted for variables in ^c^ as well as SBP, DBP and TC, HDL-C and LDL-C levels Fig. 5Generalized additive model plot for T2DM and TyG with participants without baseline IFG and MetS. *IFG* impaired fasting glucose, *MetS* metabolic syndrome, *T2DM* type 2 diabetes mellitus, *TyG index* triglyceride glucose index. Adjusted for gender, age, family history of diabetes, waist circumference (WC), systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C)

Discussion {#Sec13}
==========

This population-based prospective cohort study suggests a cumulative increased risk of incident T2DM with increasing TyG index in rural Chinese people with normal weight. These findings appeared to extend the risk of T2DM to normal-weight participants without baseline metabolic syndrome and impaired FPG level. To our knowledge, this study is the first to demonstrate a significant association between TyG index, a biomarker of IR, and incident T2DM in rural normal-weight Chinese people. This association was particularly evident for women of all age groups and for older men, which may due to the abdominal fat distribution for different sex/age groups in our population (Table [3](#Tab3){ref-type="table"}). In addition, women tend to have higher hepatocellular lipids, both fasting and after glucose and lipid loading as compared with men \[[@CR29], [@CR30]\]. As people age, visceral adiposity tissue is significantly increased for both genders, which can increase the risk of T2DM \[[@CR29]\]. As well, risk of incident T2DM was increased with high TyG value at follow-up for normal-weight people, which agrees with results from Korea \[[@CR31]\].

Many observational studies demonstrated that more than 30% of normal-weight people have metabolic abnormalities (MONW-like phenotype), including abdominal fat accumulation and IR \[[@CR11], [@CR32], [@CR33]\]. Prospective cohort studies have demonstrated increased risk of T2DM in people with MONW in different ethnic groups \[[@CR11], [@CR33], [@CR34]\]. Data from the Whitehall II study showed that the incidence of T2DM for MONW people was 12.46/1000 person-years, and the risk of incident T2DM was more than threefold increased as compared with metabolically healthy and normal weight people \[[@CR11]\]. Similar results were observed in an Asian population \[[@CR33]\]. However, measures to prevent T2DM in normal-weight people are lacking. Our results provide evidence that the TyG index can be an important indicator for predicting T2DM among normal-weight people.

Decreased β-cell function and IR are considered central events in the development of T2DM \[[@CR35]\]. Islets have intrinsically low antioxidant enzyme defenses; elevated glucose concentrations increasing levels of reactive oxygen species in β cells have toxic effects on β cells, further leading to IR and T2DM \[[@CR36]\]. Under conditions such as lipodystrophy, the lipolysis is enhanced, and prolonged fatty-acid exposure in β cells can decrease glucose-induced insulin secretion, impair insulin gene expression, and increase cell death \[[@CR37]--[@CR39]\]. As well, TG overload in islets interferes with glucose metabolism and impairs the function of β cells \[[@CR40]\]. When both fatty acids and glucose are elevated, the accumulation of metabolites derived from fatty-acid esterification impairs β-cell function \[[@CR36]\]. Changes in TG and HDL-C have a unidirectional relationship with peripheral IR, which provides evidence for the early prevention of IR by improving dyslipidemia \[[@CR41]\]. Studies of diabetes patients added that the capacity for insulin secretion and IR are closely affected by TG and FPG levels \[[@CR42]--[@CR44]\], which was also confirmed in an intervention study \[[@CR45]\]. After appropriate treatment of high TG and high FPG level by n-3 fatty acids in patients with impaired glucose metabolism, the ability of insulin secretion was improved \[[@CR45]\].

Visceral adipose tissue is associated with increased cytokine production and IR \[[@CR46]\]. Epidemiology studies have found BMI inadequate to define obesity; it cannot adequately discriminate between fat mass and lean tissues nor identify regional body fat distribution \[[@CR47]--[@CR49]\]. A population-based cross-sectional study of Chinese people showed T2DM significantly associated with central obesity among adults with normal BMI \[[@CR47]\]. Another study of a Japanese population demonstrated risk of prediabetes with upper-normal WC for people with normal WC and BMI after adjusting for BMI \[[@CR48]\]. This situation may explain why some people with normal BMI show significantly increased risk of T2DM. Another explanation may be inherited genetic factors. The genetic variation near insulin receptor substrate 1 (*IRS1*) is associated with low body fat but also impaired metabolic profile, including decreased subcutaneous-to-visceral fat ratio, increased insulin resistance, dyslipidemia, risk of diabetes and coronary artery disease, and decreased adiponectin level \[[@CR49]\].

TyG index, a biomarker related to IR \[[@CR50], [@CR51]\], can be used in clinical practice because measuring TG and glucose is inexpensive and routine. As compared with the hyperinsulinemic-euglycemic clamp, the TyG index showed high sensitivity (96.5%) and specificity (85.0%) for diagnosis of insulin resistance in Mexican people \[[@CR52]\]. The validation study was conducted in a Brazilian population, and TyG index performed better than homeostatic model assessment for measuring IR in clinical practice \[[@CR16]\]. In a 4-year retrospective longitudinal study of Korean people, high baseline TyG index was related to T2DM development regardless of obesity status \[[@CR53]\]. Therefore, the TyG index may be clinically important for preventing T2DM. However, compared with other routine biomarkers, the ability of TyG to identify IR or T2DM was controversial in different ethnic groups. TyG index did not improve diabetes prediction as compared with FPG, 1-h plasma glucose, and 2-h plasma glucose in an Iranian population \[[@CR54]\]. However, in a large European population, TyG index was a better predictor than FPG or TG level of T2DM development in normoglycemic people \[[@CR15]\]. Compared with obesity-related markers (BMI and WC) and single lipid markers (TC, TG, HDL-C, and LDL-C), TyG index had a larger AUC for identifying IR and diabetes but lower than the markers combining TyG and obesity (TyG-WC and TyG-BMI) for Chinese people \[[@CR55], [@CR56]\]. In the present study, the ability of TyG index to predict incident T2DM was similar to WC and WHtR for men but better than WC or WHtR for women.

For normal-weight people, only one study conducted in rural Korea reported that TyG index was useful for predicting the incidence of T2DM in both men and women \[[@CR33]\]. Hence, the index needs to be validated to identify T2DM in normal-weight people in different ethnic groups. In our rural Chinese normal-weight population, risk of incident T2DM increased with increasing TyG value, and the association was almost linear for people with baseline normal FPG level and metabolic health.

The strengths of the study include its prospective design, large community-based sample of men and women across a broad age spectrum, high rates of participation, standardized high-quality clinical and laboratory procedures, and adjustment for a large number of potential confounders. We also conducted a sensitivity analysis to assess the robustness of the association between TyG index and incident T2DM risk by rerunning all the models excluding participants with metabolic syndrome and impaired FPG level at baseline.

However, the study has several limitations. First, we did not use 2-h oral glucose tolerance test and glycated haemoglobin (HbA~1c~) for diagnosing T2DM, so we may have underestimated the incidence of T2DM. As well, most of our participants were not clear about whether they used lipid-lowering medications, so we did not include this variable in the analysis. Finally, because all participants were rural Chinese people, the applicability and utility of TyG index for predicting T2DM in normal-weight people should be confirmed in other ethnic populations.

Conclusions {#Sec14}
===========

Our study suggests an increased risk of T2DM with increasing TyG index for normal-weight people in a Chinese rural cohort, particularly women. TyG may be useful for predicting T2DM among normal-weight people.

AUC

:   area under the receiver operation characteristic curve

BMI

:   body mass index

CI

:   confidence interval

DBP

:   diastolic blood pressure

FPG

:   fasting plasma glucose

HDL-C

:   high-density lipoprotein cholesterol

HR

:   hazard ratio

IR

:   insulin resistance

MONW

:   metabolically obese but normal weight

LDL-C

:   low-density lipoprotein cholesterol

ROC

:   receiver operating characteristic

SBP

:   systolic blood pressure

T2DM

:   type 2 diabetes mellitus

TC

:   total cholesterol

TG

:   triglyceride

TyG

:   triglyceride glucose

TyG-D

:   difference in TyG value at the end of follow-up minus that at baseline

WC

:   waist circumference

WHtR

:   waist-to-height ratio
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